Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1192 | 1398 | 1173 | 676 | 1404 | - |
Fund Return | 19.2% | 39.83% | 17.34% | -12.26% | 7.03% | - |
Place in category | 56 | 44 | 66 | 210 | 103 | - |
% in Category | 9 | 6 | 11 | 53 | 42 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
China Southern CSI500 Fd ETF Fdr A | 9.43B | 8.62 | -5.05 | 2.83 | ||
Southern China Good Returns Fund A | 4.34B | 11.61 | -8.32 | 8.61 | ||
China Southern Transform Growth All | 4.06B | 10.00 | -5.06 | - | ||
China Southern CSI300 Fd ETF Fdr A | 4.05B | 15.98 | -4.29 | 5.75 | ||
China Southern Healthcare Balanced | 3.26B | -7.29 | -18.56 | 8.44 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Zhong Ou Modern Pioneer InitiatingA | 13.27B | 7.35 | -11.96 | - | ||
TianHong ChiNext Index A | 9.62B | 17.24 | -12.71 | - | ||
TianHong ChiNext Index C | 9.62B | 17.01 | -12.89 | - | ||
ICBC Credit Literary Ids Eq | 5.94B | 13.26 | -8.19 | - | ||
Harvest Emerging Industry Eq | 5.63B | -0.51 | -14.73 | 11.43 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
China Southern ChiNext | CNE1000037Y2 | 90.39 | 2.413 | 0.00% | |
Amperex Tech A | CNE100003662 | 0.80 | 262.71 | -2.62% | |
TREASURY COUPON BOND 2023 24 | - | 0.53 | - | - | |
TREASURY COUPON BOND 2023 16 | - | 0.35 | - | - | |
Shenzhen Mindray Bio-Medical | CNE100003G67 | 0.27 | 250.26 | -0.89% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review